BRIEF-Merck Reaffirms Commitment To Gavi, Vaccine Alliance, To Supply Low- And Middle- Income Countries With Its Hpv Vaccine

Reuters04-26

April 25 (Reuters) -

* MERCK REAFFIRMS COMMITMENT TO GAVI, VACCINE ALLIANCE, TO SUPPLY LOW- AND MIDDLE- INCOME COUNTRIES WITH ITS HPV VACCINE

* MERCK & CO INC - ON TRACK TO EXCEED GOAL OF SUPPLYING 100 MILLION DOSES OF HPV VACCINE TOGAVI-SUPPORTED COUNTRIES THROUGH 2025

* MERCK & CO INC - WE EXPECT TO SUPPLY SUFFICIENT QUANTITIES OF HPV VACCINES TO MEET ANTICIPATED DEMAND FOR ALL OF OUR HPV VACCINES IN 2025

* MERCK & CO INC: REMAINS COMMITTED TO PROVIDING A RELIABLE SUPPLY & EQUITABLE ACCESS TO OUR VACCINES FOR PEOPLE WHO USE THEM AROUND THE WORLD

* MERCK & CO INC: UPDATED INITIAL COMMITMENT TO SUPPLY A TOTAL OF 115 MILLION DOSES OF HPV VACCINE THROUGH 2025, AN INCREASE OF APPROXIMATELY 20 MILLION DOSES

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment